Status:
RECRUITING
Dexmedetomidine in Sonographic Guided Erector Spinae Plane Block
Lead Sponsor:
Assiut University
Conditions:
Pain Management
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
PHASE3
Brief Summary
to investigate the postoperative analgesic effect of dexmedetomidine addition with different doses as an adjuvant to bupivacaine to Erector spinae plane block after renal surgeries.
Eligibility Criteria
Inclusion
- Age between 18 and 70 years.
- Both sexes, males and females.
- Patients with the American Society of Anesthesiologists (ASA) physical status I/II.
- Body mass index (BMI) of 18-35 kg/m2
- Patients scheduled for elective Renal or Percutaneous Nephrolithotomy.
Exclusion
- Patients under 18 years.
- Patient refusal of nerve block.
- Infection at the site of injection.
- Coagulopathy.
- Allergy to used medications.
- Psychiatric disorder or chronic pain syndromes.
- Chronic opioid use or substance abuse.
- Quadriplegic patients.
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06899841
Start Date
October 1 2024
End Date
April 1 2026
Last Update
March 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University Hospitals
Asyut, Assiut Governorate, Egypt, 71111